Literature DB >> 1125331

Properties of the red - violet complex of copper and penicillamine and further insight into its formation reaction.

J R Wright, E Frieden.   

Abstract

A characteristic red-violet chromophore which forms in the reaction of cupric ion with beta-sulfhydryl- alpha-amino acids has been attributed by several authors to a mixed-valence Cu3L2 structure. We have isolated and examined the analogous chromophore of the chelating drug penicillamine (beta, beta-dimethyl-cysteine), finding instead a polymeric anion with a mixed valence Cu2L2 repeating unit. Direct evidence for a mixed valence polymer cooroborates earlier conclusions of Wilson and Martin (9). Under oxygen-free conditions the anionic complex forms in essentially quantitative yield according to the following reaction: (see article). It has been established that this reaction is halide ion-dependent. The chromophore may be isolated as a sodium salt. This form was found to be stable, and it possessed no measurable activity as an oxidation catalyst. It was also demonstrated through biological experiments with rabbits that a significant amount of the complex- (between 6 percent and 39 percent) is recovered in the urinary tract following intravenous infusions attaining between 1.8 and 10 ppm copper.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1125331     DOI: 10.1016/s0006-3061(00)81025-x

Source DB:  PubMed          Journal:  Bioinorg Chem        ISSN: 0006-3061


  3 in total

Review 1.  A comparative study of in vitro and in vivo interaction of D-penicillamine and triethylenetetramine with copper.

Authors:  B Sarkar; A Sass-Kortsak; R Clarke; S H Laurie; P Wei
Journal:  Proc R Soc Med       Date:  1977

2.  Biodistribution of 64Cu in inflamed rats following administration of two anti-inflammatory copper complexes.

Authors:  S J Beveridge; I R Garrett; M W Whitehouse; B Vernon-Roberts; P M Brooks
Journal:  Agents Actions       Date:  1985-10

3.  Analysis of penicillamine using Cu-modified graphene quantum dots synthesized from uric acid as single precursor.

Authors:  Gema M Durán; Tomás E Benavidez; Ana M Contento; Angel Ríos; Carlos D García
Journal:  J Pharm Anal       Date:  2017-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.